Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

MSDS

Search for MSDS (Material Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

New Lab Start-Up Program

Start up your new lab with savings on chemicals, life science reagents and other products for 3 full months

Contact Us

Contact Customer Service

Request Literature

Request literature from Sigma-Aldrich

Newsletters

Subscribe to free eNews and other newsletters from Sigma-Aldrich

Corporate

Sigma-Aldrich is a leading Life Science and High Technology Materials company focused on enabling science to improve the quality of life

Advanced Structure Search

Copy and paste, advanced query features, instant structure to name generation, element analysis and more

News & Information

St. Louis, MO - December 8, 2014 Sigma-Aldrich Again Named Top Company for Strengthening Communities through Science

Sigma-Aldrich Corporation (NASDAQ: SIAL) was named today to The Civic 50, an annual initiative that recognizes leading community-minded companies in the U.S. Conducted by Points of Light, the largest organization in the world dedicated to volunteer service, and supported byBloomberg LP, The Civic 50 honors forward-thinking businesses that are strengthening their communities and demonstrating a correlation between civic engagement and overall bottom-line benefits.

Read More
St. Louis, MO - November 6, 2014 BioReliance Implements Newly Adopted OECD Guidelines for Genetic Toxicology Testing After Participating in Regulatory Working Groups

BioReliance® (www.bioreliance.com), Sigma-Aldrich Corporation’s (NASDAQ: SIAL) biologics and early-development services business under SAFF® Commercial (www.sigmaaldrich.com/safc), announced today that its full genetic toxicology assay portfolio meets newly ratified universal Organisation for Economic Cooperation and Development (OECD) Guidelines.

Read More
St. Louis, MO - November 4, 2014 Sigma-Aldrich Completes Acquisition of Cell Marque

Sigma-Aldrich Corporation (NASDAQ: SIAL) announced it has completed its acquisition of Rocklin, California based Cell Marque Corporation, an industry-leading provider of in vitro diagnostic (IVD) antibody reagents and kits.

Read More
St. Louis, MO - October 29, 2014 SAFC Launches New Protein Quality Supplement to Increase N-linked Glycosylation

Sigma-Aldrich® Corp. (NASDAQ: SIAL) today announced that SAFC® Commercial (www.safcglobal.com), its custom manufacturing services business unit, has introduced a new protein quality supplement called EX-CELL® Glycosylation Adjust (Gal+).

Read More